Speaker: Lise Alschuler, ND, Kenneth Proefrock, NMD and Katie Stage, ND, RH (AHG), FABNG As our population ages, millions of Americans are being diagnosed with MCI: Mild Cognitive Impairment, which does not yet interfere that much with daily tasks but can progress to dementia and Alzheimer's disease (AD). Patients are told there's really nothing they can do. Many drugs have been tested for treating MCI and the early signs of AD, and just a handful have been approved. Is there another way? Panelists talk about their experiences in the clinical management of MCI, and the wide-ranging causes and possible solutions.
Related product: The PowerPoint for this recording is available here: 2023 Medicines from the Earth Herb Symposium: Conference Book Download (PDF)